Many of Australia's top brokers have been busy adjusting their financial models and recommendations. This has led to a number of broker notes being released this week.
Three ASX shares that brokers have named as buys this week are listed below. Here's why their analysts are feeling bullish on them right now:
Image source: Getty Images
CSL Ltd (ASX: CSL)
According to a note out of Morgans, its analysts have retained their buy rating on this biotech giant's shares with a reduced price target of $147.59. Morgans was disappointed to see CSL downgrade its guidance for FY 2026 due to China Albumin price pressure, US immunoglobulin channel inventory normalisation, and other impacts. However, it notes that the issues are being framed as primarily executional rather than structural, with infrastructure overbuild, organisational complexity, and weak commercial execution cited. So, with underlying demand and industry structure remaining healthy, Morgans thinks it is worth sticking with CSL and sees significant value in its shares at current levels. The CSL share price is trading at $99.13 on Wednesday.
Life360 Inc (ASX: 360)
A note out of Bell Potter reveals that its analysts have retained their buy rating on this family safety and location technology company's shares with a trimmed price target of $32.50. Bell Potter was pleased with Life360's performance in the first quarter, highlighting that it outperformed expectations for everything but monthly active users (MAUs). Life360 recorded 2 million MAU additions, compared to Bell Potter's 2.6 million estimate. However, this was due to technical issues, which have since been resolved. In light of this and recent share price weakness, Bell Potter thinks investors should be snapping up the company's shares while they can. The Life360 share price is fetching $18.69 at the time of writing.
Xero Ltd (ASX: XRO)
Analysts at Macquarie have retained their outperform rating on this cloud accounting platform provider's shares with a lowered price target of $223.60. According to the note, the broker is feeling bullish on Xero ahead of the release of its FY 2026 result on Thursday. It highlights that industry feedback in the United States has been positive, which suggests that subscriber growth could be strong in the key market. Macquarie is also feeling upbeat on Xero's AI offering and suspects that it could boost its average revenue per user metric. The Xero share price is trading at $80.80 this afternoon.
